COVID
Clinical trials for COVID explained in plain language.
Never miss a new study
Get alerted when new COVID trials appear
Sign up with your email to follow new studies for COVID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody treatment aims to stop COVID-19 in its tracks
Disease control Recruiting nowThis large international trial is testing if a single infusion of concentrated COVID-19 antibodies can help adults with a recent diagnosis. The goal is to treat people early, before they get sick enough to need the hospital, and prevent the disease from getting worse. Researchers…
Matched conditions: COVID
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New test aims to spot coronaviruses faster
Diagnosis Recruiting nowThis study is evaluating a new diagnostic test designed to detect multiple coronaviruses, including the one that causes COVID-19. Researchers will use leftover nasal swab samples from about 1,500 people who were tested for a respiratory infection. The main goal is to see how accu…
Matched conditions: COVID
Sponsor: BioFire Defense LLC • Aim: Diagnosis
Last updated Mar 24, 2026 12:02 UTC
-
New At-Home COVID test faces accuracy check in major study
Diagnosis Recruiting nowThis study is testing how accurate a new at-home COVID-19 test is compared to standard lab tests. Researchers will enroll 1,000 people across the US who currently have COVID-like symptoms. Participants will use the new test at simulated home setups near clinics, while healthcare …
Matched conditions: COVID
Phase: NA • Sponsor: Aptitude Medical Systems • Aim: Diagnosis
Last updated Mar 12, 2026 13:51 UTC
-
AI steps in: can a computer find the right cancer trial for you?
Knowledge-focused Recruiting nowThis study is testing a new artificial intelligence (AI) tool designed to help match people with advanced cancer to suitable clinical trials. It will enroll up to 50,000 patients to see if using this AI system makes it easier for patients to find and join trials. The researchers …
Matched conditions: COVID
Sponsor: Massive Bio, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC